Necitumumab
Products Necitumumab was approved as an infusion solution in the United States in 2015 and in the EU in 2016 (Portrazza). Necitumumab has not yet been registered in many countries. Structure and properties Necitumumab is a recombinant human IgG1 monoclonal antibody. It is produced by biotechnological methods. Effects Necitumumab has antitumor, antiproliferative, and antiangiogenic properties. … Necitumumab